Strong Growth Predicted For $25B U.S. Pain Management Market.

The U.S. Pain Management market will surpass the $25 billion market this year and will continue to see double-digit growth for the near future, according to a study released from Kalorama Information. Increasing rates of cancer and various surgical procedures, along with a growing patient-driven political movement to address the unmet needs of chronic pain sufferers are creating great opportunities across the spectrum of pain management.

The study, The U.S. Market for Pain Management Drugs and Devices, found the particularly fast-growing segments in the market to be spinal cord stimulator devices and certain prescription narcotic analgesics, while revenues from over-the-counter analgesics and transcutaneous electrical nerve stimulation (TENS) devices are slowing somewhat.

“The prescription narcotic segment is in an especially good position to capitalize on several intersecting trends,” notes Steven Heffner, acquisitions editor for Kalorama Information. “New clinical guidelines are urging doctors to ignore the myth that opioids are excessively dangerous at the same time that patient advocacy groups are bringing more and more patients to the physicians’ doorsteps. It’s really a marketer’s dream scenario.”

In addition to assessing the market conditions and competition in various pain therapy areas, such as migraine and arthritis, the study also looks at trends in pain management services and rehabilitation, including a look at how alternative medicine is filling some of the vacuum of unmet need. Clinical trends such as the increasing use of ambulatory patient-controlled anesthesia (PCA) infusion pumps, technological trends such as the increasing application of advanced drug delivery technologies, and business trends such as the rise of generic competition are also discussed.

For more information at http://www.KaloramaInformation.com